Why VYNE Therapeutics Stock Is Crashing Today
Shares of VYNE Therapeutics (NASDAQ: VYNE) were crashing 18.1% lower as of 11:35 a.m. EDT on Thursday. The big decline came after the company announced its first-quarter results before the market opened.
VYNE reported Q1 revenue of $4.1 million, up from $1.8 million in the prior-year period. Despite the significant year-over-year increase, this result fell well below the average analyst revenue estimate of $5.3 million.
Image source: Getty Images.
Source Fool.com
